Literature DB >> 18427433

Robotic assisted laparoscopic radical prostatectomy: evolution and outcomes.

S P Sterrett1, D F Jarrard.   

Abstract

Robotic assisted laparoscopic prostatectomy (RALP) is rapidly gaining acceptance in the urologic community as an effective treatment modality for the treatment of localized prostate cancer. For the open surgeon, this technology assists in the transition to laparoscopic-based surgery. With early stage cancer, the absence of tactile feedback appears to be offset by the superior visualization and instrumentation that the daVinci robot (Intuitive Surgical, Sunnyvale, CA, USA) provides. Economical considerations also appear to be outweighed by patient demand and benefits. Short-term perioperative, functional, and oncological outcomes all appear to be equivalent to the gold standard, open radical retropubic prostatectomy. In conclusion, RALP is an excellent option for patients considering prostate cancer treatment and should be part of the urologic surgeon's armamentarium.

Entities:  

Mesh:

Year:  2008        PMID: 18427433

Source DB:  PubMed          Journal:  Minerva Urol Nefrol        ISSN: 0393-2249            Impact factor:   3.720


  3 in total

1.  Concurrent and predictive validation of robotic simulator Tube 3 module.

Authors:  Jae Yoon Kim; Seung Bin Kim; Jong Hyun Pyun; Hyung Keun Kim; Seok Cho; Jeong Gu Lee; Je Jong Kim; Jun Cheon; Seok Ho Kang; Sung Gu Kang
Journal:  Korean J Urol       Date:  2015-11-03

2.  Does robot-assisted laparoscopic radical prostatectomy enable to obtain adequate oncological and functional outcomes during the learning curve? From the Korean experience.

Authors:  Young Hwii Ko; Jeong Hyeon Ban; Seok Ho Kang; Hong Seok Park; Jeong Gu Lee; Duck Ki Yoon; Je Jong Kim; Jun Cheon; Vipul R Patel
Journal:  Asian J Androl       Date:  2009-01-19       Impact factor: 3.285

3.  Extraperitoneal robot-assisted laparoscopic radical prostatectomy: Initial experience.

Authors:  Prem Nath Dogra; Ashish Kumar Saini; Prabhjot Singh; Girdhar Bora; Brusabhanu Nayak
Journal:  Urol Ann       Date:  2014-04
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.